BACKGROUND: The myocardium is unable to regenerate because cardiomyocytes cannot replicate after injury. The heart is therefore an attractive target for tissue engineering to replace infarcted myocardium and enhance cardiac function. We tested the feasibility of bioengineering cardiac tissue within novel 3-dimensional (3D) scaffolds. METHODS AND RESULTS: We isolated and grew fetal cardiac cells within 3D porous alginate scaffolds. The cell constructs were cultured for 4 days to evaluate viability and morphology before implantation. Light microscopy revealed that within 2 to 3 days in culture, the dissociated cardiac cells form distinctive, multicellular contracting aggregates within the scaffold pores. Seven days after myocardial infarction, rats were randomized to biograft implantation (n=6) or sham-operation (n=6) into the myocardial scar. Echocardiography study was performed before and 65+/-5 days after implantation to assess left ventricular (LV) remodeling and function. Hearts were harvested 9 weeks after implantation. Visual examination of the biograft revealed intensive neovascularization from the neighboring coronary network. Histological examination revealed the presence of myofibers embedded in collagen fibers and a large number of blood vessels. The specimens showed almost complete disappearance of the scaffold and good integration into the host. Although control animals developed significant LV dilatation accompanied by progressive deterioration in LV contractility, in the biograft-treated rats, attenuation of LV dilatation and no change in LV contractility were observed. CONCLUSIONS: Alginate scaffolds provide a conducive environment to facilitate the 3D culturing of cardiac cells. After implantation into the infarcted myocardium, the biografts stimulated intense neovascularization and attenuated LV dilatation and failure in experimental rats compared with controls. This strategy can be used for regeneration and healing of the infarcted myocardium.
BACKGROUND: The myocardium is unable to regenerate because cardiomyocytes cannot replicate after injury. The heart is therefore an attractive target for tissue engineering to replace infarcted myocardium and enhance cardiac function. We tested the feasibility of bioengineering cardiac tissue within novel 3-dimensional (3D) scaffolds. METHODS AND RESULTS: We isolated and grew fetal cardiac cells within 3D porous alginate scaffolds. The cell constructs were cultured for 4 days to evaluate viability and morphology before implantation. Light microscopy revealed that within 2 to 3 days in culture, the dissociated cardiac cells form distinctive, multicellular contracting aggregates within the scaffold pores. Seven days after myocardial infarction, rats were randomized to biograft implantation (n=6) or sham-operation (n=6) into the myocardial scar. Echocardiography study was performed before and 65+/-5 days after implantation to assess left ventricular (LV) remodeling and function. Hearts were harvested 9 weeks after implantation. Visual examination of the biograft revealed intensive neovascularization from the neighboring coronary network. Histological examination revealed the presence of myofibers embedded in collagen fibers and a large number of blood vessels. The specimens showed almost complete disappearance of the scaffold and good integration into the host. Although control animals developed significant LV dilatation accompanied by progressive deterioration in LV contractility, in the biograft-treated rats, attenuation of LV dilatation and no change in LV contractility were observed. CONCLUSIONS:Alginate scaffolds provide a conducive environment to facilitate the 3D culturing of cardiac cells. After implantation into the infarcted myocardium, the biografts stimulated intense neovascularization and attenuated LV dilatation and failure in experimental rats compared with controls. This strategy can be used for regeneration and healing of the infarcted myocardium.
Authors: Amanda J Leblanc; Jeremy S Touroo; James B Hoying; Stuart K Williams Journal: Am J Physiol Heart Circ Physiol Date: 2011-12-02 Impact factor: 4.733
Authors: Thomas Boudou; Wesley R Legant; Anbin Mu; Michael A Borochin; Nimalan Thavandiran; Milica Radisic; Peter W Zandstra; Jonathan A Epstein; Kenneth B Margulies; Christopher S Chen Journal: Tissue Eng Part A Date: 2012-01-04 Impact factor: 3.845
Authors: Luda Khait; Louise Hecker; Nicole R Blan; Garrett Coyan; Francesco Migneco; Yen-Chih Huang; Ravi K Birla Journal: J Cardiovasc Transl Res Date: 2008-01-29 Impact factor: 4.132
Authors: Megan K Proulx; Shawn P Carey; Lisa M Ditroia; Craig M Jones; Michael Fakharzadeh; Jacques P Guyette; Amanda L Clement; Robert G Orr; Marsha W Rolle; George D Pins; Glenn R Gaudette Journal: J Biomed Mater Res A Date: 2011-02 Impact factor: 4.396
Authors: Kazuro L Fujimoto; Kelly C Clause; Li J Liu; Joseph P Tinney; Shivam Verma; William R Wagner; Bradley B Keller; Kimimasa Tobita Journal: Tissue Eng Part A Date: 2011-01-16 Impact factor: 3.845